C3a



C3a

S1SS1V2VV2Q3QQ3L4LL4M5MM5E6EE6R7RR7R8RR8M9MM9D10DD10K11KK11A12AA12G13GG13Q14QQ14Y15YY15T16TT16D17DD17K18KK18G19GG19L20LL20R21RR21K22KK22C23CC23C24CC24E25EE25D26DD26G27GG27M28MM28R29RR29D30DD30I31II31P32PP32M33MM33P34PP34Y35YY35S36SS36C37CC37Q38QQ38R39RR39R40RR40A41AA41R42RR42L43LL43I44II44T45TT45Q46QQ46G47GG47... and 31 more residue(s)...... and 31 more residue(s)

SMILES None
InChIKey None
Sequence SVQLMERRMDKAGQYTDKGLRKCCEDGMRDIPMPYSCQRRARLITQGESCLKAFMDCCNYITKLREQHRRDHVLGLAR

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

C3a

S1SS1V2VV2Q3QQ3L4LL4M5MM5E6EE6R7RR7R8RR8M9MM9D10DD10K11KK11A12AA12G13GG13Q14QQ14Y15YY15T16TT16D17DD17K18KK18G19GG19L20LL20R21RR21K22KK22C23CC23C24CC24E25EE25D26DD26G27GG27M28MM28R29RR29D30DD30I31II31P32PP32M33MM33P34PP34Y35YY35S36SS36C37CC37Q38QQ38R39RR39R40RR40A41AA41R42RR42L43LL43I44II44T45TT45Q46QQ46G47GG47... and 31 more residue(s)...... and 31 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.